Alcon Inc. (ALC) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $71.44 (+0.45%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | Larry Biegelsen | Wells Fargo | $97.00 | +35.8% |
| Nov 14, 2025 | Susannah Ludwig | Bernstein | $101.09 | +41.5% |
| Oct 13, 2025 | Matt Miksic | Barclays | $86.00 | +20.4% |
| Sep 29, 2025 | Thomas Stephan | Stifel Nicolaus | $85.00 | +19.0% |
| Jul 14, 2025 | Ryan Zimmerman | BTIG | $100.00 | +40.0% |
| Oct 15, 2024 | Brett Fishbin | KeyBanc | $107.00 | +49.8% |
| Aug 22, 2024 | Jeff Johnson | Robert W. Baird | $110.00 | +54.0% |
| Aug 22, 2024 | David Saxon | Needham | $107.00 | +49.8% |
| Aug 22, 2024 | Larry Biegelsen | Wells Fargo | $105.00 | +47.0% |
| Aug 22, 2024 | Steven Lichtman | Oppenheimer | $110.00 | +54.0% |
| Jul 15, 2024 | Patrick Wood | Morgan Stanley | $85.00 | +19.0% |
| May 16, 2024 | Anthony Petrone | Mizuho Securities | $105.00 | +47.0% |
| May 15, 2024 | Steve Lichtman | Oppenheimer | $103.00 | +44.2% |
| May 15, 2024 | Jeff Johnson | Robert W. Baird | $104.00 | +45.6% |
| May 15, 2024 | Larry Biegelsen | Wells Fargo | $94.00 | +31.6% |
| May 14, 2024 | Tom Stephan | Stifel Nicolaus | $100.00 | +40.0% |
| May 14, 2024 | Anthony Petrone | Jefferies | $105.00 | +47.0% |
| May 14, 2024 | Brett Fishbin | KeyBanc | $96.00 | +34.4% |
| May 14, 2024 | David Saxon | Needham | $101.00 | +41.4% |
| May 14, 2024 | Ryan Zimmerman | BTIG | $92.00 | +28.8% |
Top Analysts Covering ALC
ALC vs Sector & Market
| Metric | ALC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.12 | 2.25 | 2.41 |
| Analyst Count | 16 | 8 | 19 |
| Target Upside | +3.7% | +153002.0% | +21.5% |
| P/E Ratio | 43.30 | 3.43 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.06B | $11.12B | $11.18B | 16 |
| 2027-03-31 | $3.03B | $3.07B | $3.11B | 4 |
| 2027-06-30 | $3.07B | $3.12B | $3.16B | 6 |
| 2027-09-30 | $2.76B | $2.80B | $2.84B | 4 |
| 2027-12-31 | $2.86B | $2.90B | $2.94B | 7 |
| 2028-03-31 | $3.07B | $3.12B | $3.16B | 3 |
| 2028-06-30 | $3.06B | $3.11B | $3.15B | 5 |
| 2028-09-30 | $3.05B | $3.10B | $3.14B | 3 |
| 2028-12-31 | $3.19B | $3.24B | $3.28B | 6 |
| 2029-12-31 | $13.20B | $13.35B | $13.55B | 9 |
| 2030-12-31 | $14.18B | $14.34B | $14.56B | 13 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.26 | $3.44 | $3.83 | 16 |
| 2027-03-31 | $0.97 | $0.99 | $1.01 | 1 |
| 2027-06-30 | $0.96 | $0.98 | $0.99 | 1 |
| 2027-09-30 | $0.92 | $0.93 | $0.95 | 1 |
| 2027-12-31 | $0.96 | $0.98 | $1.00 | 1 |
| 2028-03-31 | $1.12 | $1.14 | $1.16 | 2 |
| 2028-06-30 | $1.09 | $1.11 | $1.13 | 2 |
| 2028-09-30 | $1.12 | $1.15 | $1.17 | 2 |
| 2028-12-31 | $1.14 | $1.16 | $1.18 | 2 |
| 2029-12-31 | $4.97 | $5.04 | $5.14 | 11 |
| 2030-12-31 | $5.62 | $5.70 | $5.81 | 5 |
Frequently Asked Questions
What is the analyst consensus for ALC?
The consensus among 16 analysts covering Alcon Inc. (ALC) is Buy with an average price target of $73.43.
What is the highest price target for ALC?
The highest price target for ALC is $110.00, set by Jeff Johnson at Robert W. Baird on 2024-08-22.
What is the lowest price target for ALC?
The lowest price target for ALC is $76.00, set by Susannah Ludwig at Bernstein on 2024-01-23.
How many analysts cover ALC?
16 analysts have issued ratings for Alcon Inc. in the past 12 months.
Is ALC a buy or sell right now?
Based on 16 analyst ratings, ALC has a consensus rating of Buy (2.12/5) with a +3.7% upside to the consensus target of $73.43.
What are the earnings estimates for ALC?
Analysts estimate ALC will report EPS of $3.44 for the period ending 2026-12-31, with revenue estimated at $11.12B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.